You are here

J&J invests in experimental drugs as competitive threats loom

New York

JOHNSON & JOHNSON is investing in a collection of experimental drugs with blockbuster potential, treating widespread illnesses such as blood cancer and Alzheimer's disease, to help rise above looming competitive threats to its pharmaceutical business.

The world's

sentifi.com

Market voices on:

Powered by GET.comGetCom